Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding C Sánchez, J Hyttel Cellular and molecular neurobiology 19, 467-489, 1999 | 573 | 1999 |
Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data C Sanchez, KE Asin, F Artigas Pharmacology & therapeutics 145, 43-57, 2015 | 563 | 2015 |
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer J Hyttel, KP Bøgesø, J Perregaard, C Sanchez Journal of Neural Transmission/General Section JNT 88, 157-160, 1992 | 422 | 1992 |
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder A Mørk, A Pehrson, LT Brennum, SM Nielsen, H Zhong, AB Lassen, ... Journal of Pharmacology and Experimental Therapeutics 340 (3), 666-675, 2012 | 356 | 2012 |
Escitalopram versus citalopram: the surprising role of the R-enantiomer C Sánchez, KP Bøgesø, B Ebert, EH Reines, C Braestrup Psychopharmacology 174, 163-176, 2004 | 349 | 2004 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: Are they all alike? C Sanchez, E Meier Psychopharmacology 129, 197-205, 1997 | 339 | 1997 |
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and … C Sanchez, PBF Bergqvist, LT Brennum, S Gupta, S Hogg, A Larsen, ... Psychopharmacology 167, 353-362, 2003 | 338 | 2003 |
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? C Sanchez, EH Reines, SA Montgomery International clinical psychopharmacology 29 (4), 185-196, 2014 | 314 | 2014 |
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs E Dale, B Bang-Andersen, C Sánchez Biochemical pharmacology 95 (2), 81-97, 2015 | 293 | 2015 |
Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain M El Mansari, C Sánchez, G Chouvet, B Renaud, N Haddjeri Neuropsychopharmacology 30 (7), 1269-1277, 2005 | 231 | 2005 |
The S-enantiomer of R, S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter … F Chen, MB Larsen, C Sánchez, O Wiborg European Neuropsychopharmacology 15 (2), 193-198, 2005 | 218 | 2005 |
The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats A Mørk, M Kreilgaard, C Sanchez Neuropharmacology 45 (2), 167-173, 2003 | 214 | 2003 |
Stress-induced vocalisation in adult animals. A valid model of anxiety? C Sánchez European Journal of Pharmacology 463 (1-3), 133-143, 2003 | 213 | 2003 |
Escitalopram (S‐enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model SA Montgomery, H Loft, C Sánchez, EH Reines, M Papp Pharmacology & toxicology 88 (5), 282-286, 2001 | 205 | 2001 |
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice C Sánchez, J Arnt, J Hyttel, EK Moltzen Psychopharmacology 110, 53-59, 1993 | 204 | 1993 |
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction AL Pehrson, C Sanchez CNS spectrums 19 (2), 121-133, 2014 | 196 | 2014 |
Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice SL Hansen, BB Sperling, C Sánchez Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (1), 105-113, 2004 | 194 | 2004 |
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—a rat microdialysis and electrophysiology study AL Pehrson, T Cremers, C Bétry, MGC van der Hart, L Jørgensen, ... European Neuropsychopharmacology 23 (2), 133-145, 2013 | 182 | 2013 |
Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro J Arnt, J Hyttel, C Sánchez European journal of pharmacology 213 (2), 259-267, 1992 | 179 | 1992 |
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants AL Pehrson, C Sanchez Drug design, development and therapy, 603-624, 2015 | 176 | 2015 |